Insertion–deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab
Hyung‐Don Kim, Min‐Hee Ryu, Young Soo Park, Sun Young Lee, Meesun Moon, Yoon‐Koo Kang
Topics & Concepts
MedicineIndelNivolumabInternal medicineHazard ratioCancerSurvival rateOncologyGastroenterologyPopulationFrameshift mutationMutationConfidence intervalGenotypeGeneticsGeneImmunotherapyBiologySingle-nucleotide polymorphismEnvironmental healthGastric Cancer Management and OutcomesCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics